Effect of Muscle Strengthening Training with Pilates Reformer on Overweight/obese and Normal Body Weight Women (PRET) (PRET)

January 8, 2025 updated by: Syrou Niki, RN,MPH, PhD, University of Thessaly

The Physiological Responses of Muscle Strengthening Training with Pilates Reformer in Overweight-obese Women and Women with Normal Body Weight

This study investigates the physiological responses and the metabolic burden of a Pilates Reformer strength training session in physically inactive premenopausal women with a body mass index of 18-24.9 and 25.01-39.9. The sample included 20 women divided into two groups: 10 with normal weight (NW) and 10 with overweight/obesity (OB). In a non-randomised control design, the participants will perform a 60-minute muscle-strengthening session with Pilates Reformer equipment.

Study Overview

Detailed Description

Pilates Reformer (PR) is one of the most popular types of exercise worldwide and is considered a gentle and safe method for untrained and overweight people. The PR training approach has been found to contribute positively to various health conditions (vascular function, blood pressure, physical fitness, musculoskeletal problems), improving the quality of life and mental well-being of the participants. At the same time, it seems that it can have a positive effect on the lipid profile and other biochemical markers such as insulin and fasting glucose. Furthermore, muscle strengthening training with PR equipment provides better levels of mobility, increasing active range of motion, and also provides greater pelvic and trunk stability for both adult and middle-aged participants.

This study is designed to investigate the physiological and metabolic burden of a muscle-strengthening session with PR equipment in 20 pre-menopausal and physically inactive women with a body mass index (BMI) of 18-24, 99 & 25.01-39.9, as well as to determine the contribution of energy systems (mitochondrial, glycolytic) during and after the exercise. Each training session will last approximately 60 minutes, will be led by at least one trainer, and will include a warm-up of 7-10 minutes, muscle strengthening and mobility exercises of 35 minutes, and a recovery of 5 minutes. Anthropometric indicators, dietary intake, resting heart rate, blood lactate, resting metabolic rate, muscle soreness, rate of perceived exertion, blood pressure, and performance measurements will be measured at baseline. The metabolic cost during PR training session will be estimated from heart rate, blood lactate, resting oxygen uptake, exercise oxygen uptake, and excess post-exercise oxygen consumption measurements using a portable gas analyzer. After the PR training session will be measured the rate of perceived exertion, blood pressure, blood lactate, and muscle soreness levels.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Thessaly
      • Trikala, Thessaly, Greece, 42100
        • Department of Physical Education and Sport Science
      • Trikala, Thessaly, Greece, 42100
        • Department of Physical Education and Sports Science, University of Thessaly

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Be approved for participation by an orthopedist and internist
  • Have not followed any diet or nutritional supplements for weight loss in the last six months before the study
  • The group with overweight/obesity will consist of women with a body mass index of 25.01 - 39.9 kg/m2
  • Be physically Inactive in the last six months before the study.

Exclusion Criteria:

  • Musculoskeletal injury
  • Weight loss>10% in 6 months
  • <20 years
  • >50 years
  • Μenopause
  • Chronic diseases
  • Use of alcohol, caffeine and any type of ergogenic supplements or medication during the study
  • Physically active.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pilates Reformer Training (OW)
A group of women with overweight/obesity in this arm will participate in a 60-minute muscle-strengthening training session with Pilates Reformer equipment.
Participants will perform a 60-minute Pilates Reformer muscle-strengthening session. The training will include a 7-10 minute warm-up, 35 minutes of muscle strengthening and mobility exercises and a 5-minute recovery. During the training, the physiological responses and the energy expenditure of the participants will be recorded.
Experimental: Pilates Reformer Training (NW)
A group of women with normal weight in this arm will participate in a 60-minute muscle-strengthening training session with Pilates Reformer equipment.
Participants will perform a 60-minute Pilates Reformer muscle-strengthening session. The training will include a 7-10 minute warm-up, 35 minutes of muscle strengthening and mobility exercises and a 5-minute recovery. During the training, the physiological responses and the energy expenditure of the participants will be recorded.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in exercise-induced energy expenditure
Time Frame: At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Exercise energy expenditure (kcal) will be measured using a portable indirect calorimetry system
At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Change in excess post-exercise oxygen consumption (EPOC)
Time Frame: At 30 minutes after the exercise session (single bout lasting 60 minutes)
EPOC (kcal) will be measured using a portable indirect calorimetry system
At 30 minutes after the exercise session (single bout lasting 60 minutes)
Change in blood lactate concentration (BLa)
Time Frame: At pre- and post-exercise session (single bout) at 4 minutes post-exercise
BLa (mmol/L) concentration will be measured in a microphotometer with commercially available kits
At pre- and post-exercise session (single bout) at 4 minutes post-exercise
Change in heart rate
Time Frame: At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Heart rate (bpm) will be measured with a wearable heart rate monitor
At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Change in perceived exertion
Time Frame: At pre- and post-exercise session (single bout) at 4 minutes post-exercise.
Rating of perceived exertion (RPE) will be measured with the Borg scale (0-10)
At pre- and post-exercise session (single bout) at 4 minutes post-exercise.
Respiratory Exchange Ratio (RER)
Time Frame: At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Respiratory Exchange Ratio (RER) will be measured using a portable indirect calorimetry system
At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Breath Frequency (BF)
Time Frame: At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Breath Frequency (BF) will be measured using a portable indirect calorimetry system
At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Change in oxygen consumption
Time Frame: At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Oxygen consumption will be measured using a portable indirect calorimetry system
At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body mass index (BMI)
Time Frame: At baseline
BMI will be calculated using the Quetelet's equation
At baseline
Waist circumference (WC)
Time Frame: At baseline
WC (cm) will be measured using a Gullick II tape
At baseline
Hip circumference (HC)
Time Frame: At baseline
HC (cm) will be measured using a Gullick II tape
At baseline
Waist-to-hip ratio (WHR)
Time Frame: At baseline
WHR will be calculated by dividing the waist by the hip measurement
At baseline
Resting metabolic rate (RMR)
Time Frame: At baseline
RMR (kcal) will be measured using a portable open-circuit indirect calorimeter with a ventilated hood system
At baseline
Fat mass (FM)
Time Frame: At baseline
FM (kg) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)
At baseline
Fat-free mass (FFM)
Time Frame: At baseline
FFM (kg) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)
At baseline
Dietary intake
Time Frame: At baseline
Dietary intake will be assesed over a 7-day period using diet recalls
At baseline
Peak Maximal oxygen consumption (Peak VO2)
Time Frame: At baseline
Peak VO2 will be estimated by open circuit spirometry via breath by breath method
At baseline
Bone mass density
Time Frame: At baseline
Bone mass density will be measured by using Dual-emission X-ray absorptiometry
At baseline
Bone mass content
Time Frame: At baseline
Bone mass content will be measured by using Dual-emission X-ray absorptiometry
At baseline
Rest Heart Rate
Time Frame: At baseline
The rest heart rate will be estimated using a heart rate monitor
At baseline
Body fat (BF)
Time Frame: At baseline
Body fat (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)
At baseline
Body weight
Time Frame: At baseline and at 40 minutes after the exercise session.
Body weight will be measured on a beam balance with a stadiometer
At baseline and at 40 minutes after the exercise session.
Body height
Time Frame: At baseline
Body height will be measured on a beam balance with a stadiometer
At baseline
Systolic Blood Pressure
Time Frame: At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Systolic Blood Pressure will be examined using a sphygmomanometer
At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Diastolic Blood Pressure
Time Frame: At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Diastolic Blood Pressure will be examined using a sphygmomanometer
At pre-exercise, 60 minutes during PR training, and 30 minutes after the exercise session (single bout lasting 60 minutes)
Evaluation of physical activity (PA)
Time Frame: At baseline
The PA will be evaluated for seven days before the intervention via accelerometry
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 4, 2024

Primary Completion (Actual)

December 2, 2024

Study Completion (Actual)

January 7, 2025

Study Registration Dates

First Submitted

October 31, 2024

First Submitted That Met QC Criteria

November 4, 2024

First Posted (Actual)

November 5, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 8, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Energy Expenditure

Clinical Trials on Pilates Reformer Training

Subscribe